MAP2K7 and cancer: In cancer cells, down-regulation of HMW-TPM1 expression could be the result of activation of the Ras/Raf/MEK/ERK pathway [58], or DNA methylation of TPM1 promoter [59], or over-expression of the onco-microR-21 [27].